CHICAGO — A federal court in Illinois approved a class-action settlement of $100 million concluding an eight-year-long legal battle where Walgreens shoppers said the company’s use of a discount generic-drug program called the Prescription Savings Club fraudulently inflated the usual prices reported to health insurers and led customers into overpaying. The court divides the fund pool into two pools, allocating 80% to insurance companies and benefit plans, and 20% to individual consumers. Walgreens has agreed to terminate the Prescription Savings Club.
Read the ruling here.
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.
Search Articles
